Calub C, Hertz-Picciotto I, Bennett D, Schweitzer J
JCPP Adv. 2025; 5(1):e12267.
PMID: 40060002
PMC: 11889653.
DOI: 10.1002/jcv2.12267.
Horner D, Jepsen J, Chawes B, Aagaard K, Rosenberg J, Mohammadzadeh P
Nat Metab. 2025; .
PMID: 40033007
DOI: 10.1038/s42255-025-01230-z.
Miller C, Golovina E, Gokuladhas S, Wicker J, Jacobsen J, OSullivan J
Life Sci Alliance. 2025; 8(5).
PMID: 40000109
PMC: 11861640.
DOI: 10.26508/lsa.202403029.
Leffa D, Povala G, Bellaver B, Ferrari-Souza J, Ferreira P, Lussier F
Alzheimers Dement. 2025; 21(2):e70003.
PMID: 39998851
PMC: 11853731.
DOI: 10.1002/alz.70003.
Fredriksen T, Orm S, Prentice C, Kirchhofer S, Zahl E, Botta M
J Autism Dev Disord. 2025; .
PMID: 39998724
DOI: 10.1007/s10803-025-06771-6.
Factors associated with attention-deficit/hyperactivity disorder among Tunisian children.
Guedria A, Guedria M, Ben Fredj M, Ayoub R, Ben Abid H, Mhalla A
Front Psychiatry. 2025; 16:1462099.
PMID: 39990169
PMC: 11842382.
DOI: 10.3389/fpsyt.2025.1462099.
ADHD symptom trajectories across childhood and early adolescence and risk for hypomanic symptoms in young adulthood.
Durdurak B, Morales Munoz I, Morales-Munoz I, Hosang G, Marwaha S
Eur Psychiatry. 2025; 68(1):e37.
PMID: 39967022
PMC: 11883789.
DOI: 10.1192/j.eurpsy.2025.24.
Phytoconstituents of Exert Benefits for ADHD Conditions by Targeting SLC6A4: Extraction, Spectroscopic Characterization, Phytochemical Screening, , and Computational Perspectives.
Mohan K, Ravichandran N, Rajendran H, Roshni J, Sivakumar M, Velayudam J
ACS Omega. 2025; 10(5):4261-4275.
PMID: 39959106
PMC: 11822522.
DOI: 10.1021/acsomega.4c05522.
Genome data based deep learning identified new genes predicting pharmacological treatment response of attention deficit hyperactivity disorder.
Zhao Y, Fu Z, Barnett E, Wang N, Zhang K, Gao X
Transl Psychiatry. 2025; 15(1):46.
PMID: 39920114
PMC: 11806042.
DOI: 10.1038/s41398-025-03250-5.
Heterogeneity analysis provides evidence for a genetically homogeneous subtype of bipolar-disorder.
McGrouther C, Rangan A, Di Florio A, Elman J, Schork N, Kelsoe J
PLoS One. 2025; 20(1):e0314288.
PMID: 39879180
PMC: 11778664.
DOI: 10.1371/journal.pone.0314288.
The association between maternal diabetes and the risk of attention deficit hyperactivity disorder in offspring: an updated systematic review and meta-analysis.
Damtie Y, Dachew B, Ayano G, Tadesse A, Betts K, Alati R
Eur Child Adolesc Psychiatry. 2025; .
PMID: 39873760
DOI: 10.1007/s00787-025-02645-5.
Rare Variant Analyses in Ancestrally Diverse Cohorts Reveal Novel ADHD Risk Genes.
Jung S, Caballero M, Olfson E, Newcorn J, Fernandez T, Mahjani B
medRxiv. 2025; .
PMID: 39867378
PMC: 11759603.
DOI: 10.1101/2025.01.14.25320294.
D1 dopamine receptor antagonists as a new therapeutic strategy to treat autistic-like behaviours in lysosomal storage disorders.
De Risi M, Cusimano L, Bujanda Cundin X, Pizzo M, Gigante Y, Monaco M
Mol Psychiatry. 2025; .
PMID: 39865184
DOI: 10.1038/s41380-025-02904-6.
The prevalence of attention-deficit hyperactivity disorder and its associated factors among children in Ethiopia, 2024: a systematic review and meta-analysis.
Azmeraw M, Temesgen D, Kassaw A, Zemariam A, Kerebeh G, Abebe G
Front Child Adolesc Psychiatry. 2025; 3:1425841.
PMID: 39844859
PMC: 11751470.
DOI: 10.3389/frcha.2024.1425841.
Antipsychotic Drug Prescribing in Children Previously Treated With Stimulants for ADHD: A Population-Based Longitudinal Study: La prescription d'antipsychotiques chez les enfants précédemment traités avec des stimulants pour le TDAH : une étude....
Gober H, Li K, Carleton B
Can J Psychiatry. 2025; 7067437241309679.
PMID: 39819175
PMC: 11748389.
DOI: 10.1177/07067437241309679.
Neuropsychological correlates of ADHD: indicators of different attentional profiles among youth with sluggish cognitive tempo.
Krone B, Bedard A, Schulz K, Ivanov I, Stein M, Newcorn J
Front Child Adolesc Psychiatry. 2025; 2():1208660.
PMID: 39816860
PMC: 11731839.
DOI: 10.3389/frcha.2023.1208660.
Association Between Endocrine-Disrupting Chemicals Exposure and Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Attention-Deficit/Hyperactivity Disorder.
Yeo K, Lim S, Kim A, Lim Y, Lee C, Kim J
Soa Chongsonyon Chongsin Uihak. 2025; 36(1):18-25.
PMID: 39811025
PMC: 11725660.
DOI: 10.5765/jkacap.240035.
Sex differences in psychiatric comorbidities of attention-deficit/hyperactivity disorder among children, adolescents, and adults: A nationwide population-based cohort study.
Kao P, Ho C, Huang C
PLoS One. 2025; 20(1):e0315587.
PMID: 39752340
PMC: 11698318.
DOI: 10.1371/journal.pone.0315587.
Association between prenatal tobacco exposure and attention-deficit/hyperactivity disorder related characteristics at 6 and 8 years: a birth cohort in Japan.
Itoh M, Kobayashi S, Nishihara S, Miyashita C, Yamazaki K, Tamura N
BMJ Open. 2024; 14(12):e087406.
PMID: 39725438
PMC: 11683938.
DOI: 10.1136/bmjopen-2024-087406.
Enhancing patient representation learning with inferred family pedigrees improves disease risk prediction.
Huang X, Arora J, Erzurumluoglu A, Stanhope S, Lam D, Zhao H
J Am Med Inform Assoc. 2024; 32(3):435-446.
PMID: 39723811
PMC: 11833479.
DOI: 10.1093/jamia/ocae297.